QDEL - Quidel Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Quidel Corporation

12544 High Bluff Drive
Suite 200
San Diego, CA 92130
United States
858-552-1100
http://www.quidel.com

SectorHealthcare
IndustryDiagnostics & Research
Full Time Employees1,193

Key Executives

NameTitlePayExercisedYear Born
Mr. Douglas C. BryantPres, CEO & Director960.05k1.99M1958
Mr. Randall J. StewardChief Financial Officer531.08kN/A1954
Mr. Robert J. BujarskiSr. VP of Bus. Devel., Gen. Counsel & Corp. Sec.524.15k373.36k1968
Dr. Werner KrollSr. VP of R&D508.23kN/A1957
Mr. Edward Keith RussellSr. VP of North America Operations524.08kN/A1968
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology. The company offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus products point-of-care products for the detection of infectious and inflammatory diseases and conditions of the eye. It also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine. In addition, the company offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, it provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, the company offers AmpliVue hand-held molecular diagnostic assay platform for the detection of the pathogen; Solana, an amplification and detection system; and Lyra molecular real-time polymerase chain reaction assays. The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, leading universities, retail clinics, pharmacies, and wellness screening centers. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California.

Corporate Governance

Quidel Corporation’s ISS Governance QualityScore as of July 1, 2018 is 2. The pillar scores are Audit: 2; Board: 2; Shareholder Rights: 3; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.